A Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive Symptoms

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY

The goal of this observational study is to evaluate if Danning Tablets are effective in alleviating dyspepsia in patients with any of the following digestive symptoms: upper abdominal pain, bloating, loss of appetite, acid reflux or constipation. The main questions it aims to answer are: How effective are Danning Tablets for patients with indigestion symptoms? What are the impact factors (e.g. severity of conditions, demographic features, dose and length of treatment etc.) of the efficacy of Danning Tablets for indigestion patients? Participants already taking Danning Tablets as part of their regular medical care for indigestion will take questionnaires by the end of two weeks and four weeks respectively from the start of their treatment.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Patients between 18 and 75 years old

• Patients with at least one of the following symptoms: upper abdominal pain, bloating, loss of appetite, acid reflux or constipation

• Patients already taking Danning Tablets as part of their regular medicine treatment for dyspepsia

• Patients agree to sign the informed consent form

Locations
Other Locations
China
The Second Affiliated Hospital Zhejiang University School of Medicine
RECRUITING
Hangzhou
Contact Information
Primary
Yichen GAO, Master of Pharmacy
gaoyichen@shpl.com.cn
+86 13818076897
Backup
Litao JIA, Doctor of Medicine
jialitao@zju.edu.cn
+86 13958158234
Time Frame
Start Date: 2025-04-30
Estimated Completion Date: 2027-06-30
Participants
Target number of participants: 4500
Treatments
Patients with dyspepsia symptoms taking Danning Tablets
1. Patients between 18 and 75 years old;~2. Patients with at least one of the following symptoms: upper abdominal pain, bloating, loss of appetite, acid reflux or constipation;~3. Patients already taking Danning Tablets as part of their regular medicine treatment for dyspepsia;~4. Patients agree to sign the informed consent form.
Related Therapeutic Areas
Sponsors
Collaborators: Second Affiliated Hospital, School of Medicine, Zhejiang University
Leads: Shanghai Hutchison Pharmaceuticals Limited

This content was sourced from clinicaltrials.gov